|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. POINTER shows lifestyle interventions protect brain health
The Alzheimer's Association U.S. POINTER study — a two-year clinical trial testing two lifestyle interventions in a large, diverse population of older adults at risk for cognitive decline and dementia — found that both interventions improved cognition but that the cognitive benefits were greater for the structured intervention, protecting cognition from normal age-related decline for up to two years. The results were presented at the Alzheimer's Association International Conference® 2025 (AAIC®) in Toronto and online.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Decades-old lead pollution linked to memory problems
Historic lead levels from the era of leaded gasoline may be contributing to cognitive issues 50 years later, suggests research reported for the first time at AAIC. Americans are about 20% more likely to experience memory problems if they lived in areas with high levels of atmospheric lead between 1960 and 1974, according to the analysis of more than 600,000 adults 65 and older.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Association releases clinical practice guideline for blood-based biomarker tests
In a landmark step toward transforming Alzheimer's disease diagnosis and management in specialty care, the Alzheimer's Association released at AAIC its first evidence-based clinical practice guideline on the use of blood-based biomarker (BBM) tests. The BBM guideline is our first rigorously developed guideline that provides specialist clinicians with a clear, research-informed framework for using blood tests more confidently and consistently.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
My Preferences:
|
Unsubscribe
To stop receiving our weekly e-newsletter, simply unsubscribe.
|
|
Subscribe
Was this e-newsletter forwarded to you? Subscribe to get it weekly.
|
|
|
|
The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support.
Alzheimer's Association Home Office 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601
© 2025 Alzheimer's Association. All rights reserved. www.alz.org | 800.272.3900.
|